tiprankstipranks
Trending News
More News >
AbbVie (ABBV)
NYSE:ABBV
US Market
Advertisement

AbbVie (ABBV) Technical Analysis

Compare
23,150 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
AbbVie’s (ABBV) Moving Averages Convergence Divergence (MACD) indicator is 3.79, suggesting AbbVie is a Buy.
AbbVie’s (ABBV) 20-Day exponential moving average is 225.68, while AbbVie’s (ABBV) share price is $226.87, making it a Buy.
AbbVie’s (ABBV) 50-Day exponential moving average is 216.57, while AbbVie’s (ABBV) share price is $226.87, making it a Buy.

AbbVie (ABBV) Pivot Points

Oct 18, 2025, 06:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
221.08
223.20
224.71
226.83
228.34
230.46
231.97
Fibonacci
223.20
224.59
225.44
226.83
228.22
229.07
230.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (ABBV) Moving Averages

Oct 18, 2025, 06:21 AM
Period
Simple
Exponential
MA5
227.62Sell
227.53Sell
MA10
228.86Sell
227.85Sell
MA20
226.75Buy
225.68Buy
MA50
215.55Buy
216.57Buy
MA100
201.10Buy
206.49Buy
MA200
193.61Buy
196.71Buy
AbbVie’s (ABBV) 10-Day exponential moving average is 227.85, while AbbVie’s (ABBV) share price is $226.87, making it a Sell.
AbbVie’s (ABBV) 100-Day exponential moving average is 206.49, while AbbVie’s (ABBV) share price is $226.87, making it a Buy.
AbbVie’s (ABBV) stock price is $226.87 and AbbVie’s (ABBV) 50-day simple moving average is 215.55, creating a Buy signal.
AbbVie’s (ABBV) stock price is $226.87 and AbbVie’s (ABBV) 100-day simple moving average is 201.10, creating a Buy signal.
AbbVie’s (ABBV) stock price is $226.87 and AbbVie’s (ABBV) 200-day simple moving average is 193.61, creating a Buy signal.

AbbVie (ABBV) Technical Indicators

Oct 18, 2025, 06:21 AM
Name
Value
Implied Action
RSI (14)
55.76
Neutral
STOCH (9,6)
7.70
Buy
STOCHRSI (14)
31.99
Neutral
MACD (12,26)
3.79
Buy
ADX (14)
37.08
Neutral
Williams %R
-71.70
Buy
CCI (14)
-11.97
Neutral
ATR (14)
4.90
-
Ultimate Oscillator
16.81
Sell
ROC
3.58
Buy
AbbVie’s (ABBV) Relative Strength Index (RSI) is 55.76, creating a Neutral signal.
AbbVie’s (ABBV) Trend Strength Indicator (ADX) is 37.08, creating a Neutral signal.
AbbVie’s (ABBV) Commodity Channel Index (CCI) is -11.97, creating a Neutral signal.
AbbVie’s (ABBV) Price Rate of Change (ROC) is 3.58, creating a Buy signal.

FAQ

Is ABBV a Buy, Hold, or Sell?
Based on ABBV’s technical indicators, ABBV is a Buy.
    What is ABBV’s RSI (14)?
    ABBV’s RSI (14) is 55.76, which suggests ABBV is a Neutral.
      What is ABBV’s MACD?
      ABBV’s MACD is 3.79, which suggests ABBV is a Buy.
        What is ABBV’s 5-day moving average?
        ABBV’s 5-day moving average is 227.62, which suggests ABBV is a Sell.
          What is ABBV’s 20-day moving average?
          ABBV 20-day moving average is 226.75, which suggests ABBV is a Buy.
            What is ABBV’s 50-day moving average?
            ABBV’s 50-day moving average is 215.55, which suggests ABBV is a Buy.
              What is ABBV’s 200-day moving average?
              ABBV’s 200-day moving average is 193.61, which suggests ABBV is a Buy.
                What is ABBV’s Williams % R (14)?
                ABBV’s Williams % R (14) is -71.70, which suggests ABBV is a Buy.
                  What is ABBV’s CCI (14)?
                  ABBV’s CCI (14) is -11.97, which suggests ABBV is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis